About Rusan Pharma Limited
Data last updated:
Rusan Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1994PLC077069. Its GSTIN is 27AABCR3179H1Z8 (Maharashtra). The company holds 10 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.84 Cr. It was formerly known as Rusan Pharma Private Limited. It is led by directors including Kunal Navin Saxena (Managing Director) and Balasaheb Annasaheb Patil (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 58 – D Government Industrial Estate Charkop Kandivali West, Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2025, the company reported a revenue of ₹392.15 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹48.84 Cr (net margin 12.5%) and EBITDA of ₹89.66 Cr (EBITDA margin 22.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
The company has about 656 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: Rusan Pharma and Aposan. As per MCA filings, the company has open charges of ₹279.97 Cr and satisfied charges of ₹80.83 Cr on record. Court records list 34 cases involving the company, including 16 filed by the company and 15 filed against it; 12 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rusanpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address58 – D Government Industrial Estate Charkop Kandivali West, Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Rusan Pharma Limited
Rusan Pharma operates two associated brands: Rusan Pharma and APOSAN. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing is focused on de-addiction and pain management solutions in India. | rusanpharma.com | |
| APOSAN is focused on Parkinson’s disease treatment solutions. | aposan.in |
Business Activity of Rusan Pharma Limited
The main business activity of Rusan Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rusan Pharma Limited FY 2025 filings available
Rusan Pharma Limited reported revenue of ₹392.15 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rusan Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 9% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rusan Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹89.66 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹48.84 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rusan Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rusan Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rusan Pharma Limited
Rusan Pharma has 5 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kunal Navin Saxena Also directs: Navicare Pharma Private Limited, Rusan Health Care Private Limited, Euromed International Private Limited and 5 more | Managing Director | 05 Apr 2012 | 14 Years 6 Months | Current |
| Balasaheb Annasaheb Patil | Whole-Time Director | 17 Oct 2012 | 14 Years 0 Months | Current |
| Sandeep Verma | Director | 20 Mar 2023 | 3 Years 7 Months | Current |
| Navin Satyapal Sexena Also directs: Navicare Pharma Private Limited, Rusan Health Care Private Limited, Euromed International Private Limited and 4 more | Director | 15 Mar 1994 | 32 Years 7 Months | Current |
| Aakarsh Navin Saxena Also directs: Navin Saxena Research and Technology Private Limited | Whole-Time Director | 10 Feb 2016 | 10 Years 8 Months | Current |
Peer Comparison of Rusan Pharma Limited
Rusan Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zeiss Pharmaceuticals Private Limited | ₹403.65 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Nalagarh, Himachal Pradesh, India |
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | •••• | •••• | 33.0% | •••• | Hyderabad, Telangana, India |
| Maiva Pharma Private Limited | ₹399.05 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Bangalore, Karnataka, India |
| Martin & Harris Private Limited | ₹398.47 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Novartis India Limited Listed | ₹398.23 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Rusan Pharma Limited this company | ₹392.15 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Hetero Biopharma Limited | ₹387.48 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Hyderabad, Telangana, India |
| Zim Laboratories Limited. Listed | ₹384.82 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Nagpur, Maharashtra, India |
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
| Marc Laboratories Limited | ₹383.21 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Scope Ingredients Private Limited | ₹382.39 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Rusan Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rusan Pharma Limited
Rusan Pharma Limited is audited by Gupta Saharia & Co. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Gupta Saharia & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rusan Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rusan Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2025 | Others | ₹15 Cr | Open |
| 16 Dec 2022 | Others | ₹10 Cr | Open |
| 27 Jul 2022 | Others | ₹10 Cr | Open |
| 31 Aug 2021 | Canara Bank | ₹75 Cr | Open |
| 29 Sep 2020 | Canara Bank | ₹16.5 Cr | Open |
Total charge records: 15 View all charges
Legal Cases of Rusan Pharma Limited
Rusan Pharma Limited has 34 court cases on record: 16 filed by Rusan Pharma, 15 filed against it, 3 where it is another party. 12 cases are pending and 22 are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 9 | 9 |
| High courts | 13 | 6 | 3 |
Cases on record (5 of 34)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Aumgen Pharma LLP | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Sandor Medicaids Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against Carbontree Industries Private Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Aumgen Pharma LLP | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Execution petition | Filed against the company by Blue Star Limited. | Disposed |
Full case history
All 34 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Rusan Pharma Limited
Rusan Pharma Limited has 18 MSME Form 1 returns on record between 2019 and 2023, listing 1,639 overdue payments to 131 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 131)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Dayaram Chemicals Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Saroj Art Printers Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 18 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Rusan Pharma Limited
Rusan Pharma Limited has a workforce of 656 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Rusan Pharma Limited
Rusan Pharma has 1 subsidiary company and 6 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Tuscany Holdings Private Limited | U65990MH1994PTC081494 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Rusan Pharma Limited
Rusan Pharma Limited has 13 board changes on record since 1994: 5 appointments and 8 cessations. The latest: Aakarsh Navin Saxena ceased to be Director on 30 Sep 2023.
29 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Rusan Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rusan Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rusan Pharma Limited
Rusan Pharma has 10 GST registrations: 10 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCR3179H1Z8 | Maharashtra | Active | 01 Jul 2017 |
| 27AABCR3179H2Z7 | Maharashtra | Active | 21 Sep 2017 |
| 05AABCR3179H1ZE | Uttarakhand | Active | 01 Jul 2017 |
| 24AABCR3179H1ZE | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rusan Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rusan Pharma Limited
Rusan Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 1994 (32+ years old) and is registered under CIN U24230MH1994PLC077069.
Rusan Pharma reported revenue of ₹392.15 Cr for FY 2025 (up 9% YoY).
Rusan Pharma has 5 current directors:
- Kunal Navin Saxena - Managing Director
- Balasaheb Annasaheb Patil - Whole-Time Director
- Aakarsh Navin Saxena - Whole-Time Director
- Sandeep Verma - Director
- Navin Satyapal Sexena - Director
Rusan Pharma reported a net profit of ₹48.84 Cr (net margin 12.5%) and EBITDA of ₹89.66 Cr (EBITDA margin 22.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rusan Pharma is 9% over three years and 12% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rusan Pharma is 27AABCR3179H1Z8, registered in Maharashtra. The company has 10 GST registrations in all, of which 10 are active. Other active GSTINs include 27AABCR3179H2Z7 (Maharashtra), 05AABCR3179H1ZE (Uttarakhand), 24AABCR3179H1ZE (Gujarat).
The CIN (Corporate Identification Number) of Rusan Pharma is U24230MH1994PLC077069. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rusan Pharma has 34 court cases on record: 16 filed by the company and 15 filed against it. 12 are pending. Most are in the district courts.
Rusan Pharma was incorporated on 15 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rusan Pharma by revenue are Zeiss Pharmaceuticals Private Limited, Gland Chemicals Pvt Ltd, Maiva Pharma Private Limited, Martin & Harris Private Limited, Novartis India Limited and 5 more, all in the Pharma industry (Formulations).
Aakarsh Navin Saxena ceased to be Director on 30 Sep 2023. Navin Satyapal Sexena ceased to be Director on 30 Sep 2023. Sandeep Verma was appointed as Director on 20 Mar 2023. Rusan Pharma has 13 board changes on record in total.
Rusan Pharma has 18 MSME Form 1 returns on record between 2019 and 2023, listing 1,639 overdue payments to 131 micro and small suppliers. The latest return was filed on 03 Jan 2024.